BlueLinx Q2 EPS $7.48 vs $11.61 YoY; specialty sales up 17% offset structural decline

BlueLinx Holdings Inc.

2022-Q2 EPS reported $21.07 revenue$2,541,684,000

Net income $71M ($7.48 diluted EPS) vs $113M ($11.61) Q2 2021.
Net sales $1.2B (-5% YoY); specialty products $788M (+17%), structural $452M (-29%).
Adjusted EBITDA $112M (9.1% margin) vs $166M (12.7%); operating cash $101M, free cash $97M.
Net leverage at 0.9x; available liquidity $451M all-time high; share repurchase auth increased to $100M.
Q3 early view: specialty gross margins 22-23%; structural margins 18-19% including reversal of cost adjustment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.